What is SI-BONE?
Headquartered in Santa Clara, California, SI-BONE is a medical device innovator specializing in sacropelvic solutions. The company is best known for its iFuse Technology, a minimally invasive surgical solution designed to treat sacroiliac joint dysfunction. By focusing on high-precision instrumentation and clinical evidence, SI-BONE has established itself as a critical player in the orthopedic landscape, providing surgeons with reliable tools for spinopelvic fixation and trauma management.
The company's market position is bolstered by its long-standing relationships with specialized healthcare investors who provide not only capital but also deep domain expertise in life sciences and medical technology. This strategic alignment has been instrumental in the company's ability to maintain its competitive edge in a highly regulated and technically demanding industry.
How much funding has SI-BONE raised?
SI-BONE has raised a total of $399.4M across 10 funding rounds:
Unspecified
$16M
Private Equity
$33M
Private Equity
$21M
Debt
$39.2M
Private Equity
$20M
Stock Offering
$124.2M
Stock Offering
$53.5M
Debt
$40M
Debt
$51M
Unspecified (2011): $16M led by Montreux Equity Partners and Skyline Ventures
Private Equity (2014): $33M supported by Montreux Equity Partners, Novo A/S, OrbiMed, and Skyline Ventures
Private Equity (2015): $21M featuring OrbiMed, Montreux Equity Partners, Redline Capital Management, and Skyline Ventures
Debt (2015): $39.2M backed by Silicon Valley Bank and Oxford Finance
Private Equity (2016): $20M with participation from Novo A/S, OrbiMed, Arboretum Ventures, Skyline Ventures, Montreux Equity Partners, and Redline Capital Management
Stock Issuance/Offering (2018): $124.2M, investors not publicly disclosed
Stock Issuance/Offering (2020): $53.5M, investors not publicly disclosed
Debt (2020): $40M featuring Solar Capital Partners
Debt (2023): $51M backed by Silicon Valley Bank
Key Investors in SI-BONE
Skyline Ventures
A nationally-known venture capital firm specializing in product-focused healthcare companies, including medical devices and diagnostics, led by professionals with deep clinical and operational experience.
OrbiMed
A specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and digital health platforms with a hands-on approach to strategic growth.
Montreux Equity Partners
A growth-oriented investment firm that partners with high-potential, commercial-stage companies to accelerate scale and drive category leadership in the healthcare and life sciences sectors.
What's next for SI-BONE?
Looking ahead, SI-BONE is positioned to leverage its recent capital infusion to further penetrate global markets and refine its product pipeline. The company's strategic roadmap likely involves expanding the clinical applications of its iFuse platform and investing in next-generation surgical technologies. As the healthcare sector continues to prioritize minimally invasive procedures, SI-BONE's focus on patient outcomes and surgeon-centric design will remain a primary driver of its long-term growth. The firm's ability to secure diverse financing—ranging from venture capital to debt facilities—suggests a robust financial foundation capable of supporting sustained innovation and operational scaling in the coming years.
See full SI-BONE company page
